OTRADI has access to novel and commercially available chemical compound libraries, including the following collections:
This collection of 50,000 drug-like small molecules is selected based on 3D-pharmacophore analysis.
This collection of 14,400 compounds is maximized for structural diversity and held in microtiter plates.
MicroSource Discovery: The Spectrum Collection
This collection of 2,000 compounds feature a wide range of biological activities and structural diversity.
National Cancer Institute (NCI) Libraries:
This collection of more than 2,500 compounds includes the Approved Oncology Drug Sets, Diversity Set II, Mechanistic Diversity Set and the Natural Products Set.
The Oregon Collection
This collection of more than 1,000 novel, locally sourced compounds was contributed to by chemists and scientists from Oregon’s research universities.